TIO Discovery

TIO Discovery is the internal drug discovery, research and early development engine associated with TIO Bioventures. It appears to function as a lean, self-sufficient oncology-focused organization that supports venture creation and provides drug discovery, R&D, and early-stage clinical development capabilities for portfolio companies. Publicly available information ties TIO Discovery to the creation and support of companies such as Treadwell Therapeutics and TCRyption, spanning small-molecule oncology programs and TCR-T cell therapy. The organization is positioned more as a platform and operating discovery group than as a standalone commercial biopharma with a clearly disclosed independent pipeline. Available evidence indicates a strong focus on first-in-class cancer therapeutics rooted in academic science translation.